Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
published in: Journal of Immunotherapy
date of publication: 2011-01-01
main subject: toll-like receptor, RNA vaccine
Cites articles
There is nothing here
Article - wd:Q51027487